TOTAL INTRAVENOUS ANESTHESIA USING PROPOFOL, GAMMA-HYDROXYBUTYRATE ORMIDAZOLAM IN COMBINATION WITH SUFENTANIL FOR PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-SURGERY
S. Kleinschmidt et al., TOTAL INTRAVENOUS ANESTHESIA USING PROPOFOL, GAMMA-HYDROXYBUTYRATE ORMIDAZOLAM IN COMBINATION WITH SUFENTANIL FOR PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-SURGERY, European journal of anaesthesiology, 14(6), 1997, pp. 590-599
Total intravenous anaesthesia (TIVA) using propofol, gamma-hydroxybuty
rate (GHB) or midazolam in combination with sufentanil was investigate
d in 45 patients undergoing coronary artery bypass grafting (CABG). An
aesthesia was induced with sufentanil, etomidate and pancuronium. Afte
r endotracheal intubation, anaesthesia was continued with sufentanil (
2 mu g kg(-1) h(-1)) for ail patients. Patients were randomized to rec
eive supplementary propofol (2 mg kg(-1) h(-1), n=15), gamma-hydroxybu
tyrate (20 mg kg(-1) h(-1), n=15) or midazolam (0.06 mg kg(-1) h(-1),
n=15). Haemodynamic measurements were performed after induction and at
various times in the pre-bypass period. In the propofol group, a sign
ificant decrease in heart rate (HR 12% +/- 3%), cardiac index (CI 23%
+/- 4%), mean arterial pressure (MAP 16%+/-3%) and left ventricular st
roke work index (LVSWI 17%+/-4%) occurred until sternotomy was perform
ed. With the exception of cardiac index, both midazolam and gamma-hydr
oxybutyrate produced similar haemodynamic effects: cardiac index was t
emporarily decreased (19% +/- 4%) by midazolam and remained unchanged
after gamma-hydroxy butyrate. In both groups, sternotomy was followed
by temporary hypertension, associated with a significant rise in syste
mic vascular resistance. No electrocardiographical signs of ischaemia
were observed in any patient. In the case of propofol and midazolam, g
amma-hydroxybutyrate showed adequate haemodynamic stability especially
after induction of anaesthesia and may also be a suitable agent for t
otal intravenous anaesthesia in patients with coronary artery disease.
However, during sternotomy, supplementary administration of opioids w
as required.